Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TearLab Corporation

TearLab Corporation
1996 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
TEAR STOCK SYMBOL
4 INVESTMENTS
$0.07 SHARE PRICE (As of Friday Closing)
Description

TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned subsidiary, TearLab Research Inc. Most of the company's revenue is derived from the United States region.

Website
Formerly Known As
OccuLogix
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Other Industries
Clinics/Outpatient Services
Other Healthcare Technology Systems
Stock Exchange
PINX
Primary Office
  • 150 La Terraza Boulevard
  • Suite 101
  • Escondido, CA 92025
  • United States

+1 (855) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TearLab Corporation’s full profile, request a free trial.

TearLab Corporation Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.03 - $0.15 $829K $0.07 -$0.39 31.2K 12.6M

TearLab Corporation Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 26,894 23,501 23,116 38,221
Revenue 23,150 24,999 27,119 28,014
EBITDA 1,520 3,669 (9,845) (12,414)
Net Income (4,776) (2,251) (16,101) (19,920)
Total Assets 15,919 14,513 14,345 26,627
Total Debt 36,907 32,014 28,290 26,449
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TearLab Corporation Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore TearLab Corporation‘s full profile, request access.

Request full access to PitchBook

TearLab Corporation Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (000000 0 14-Mar-2014 000000000000000000 00.00 Other Healthcare
00000000 06-Oct-2008 000000000 0000 Diagnostic Equipment 00000 00000000
00000000 31-Dec-2006 000000000000000000 000 Diagnostic Equipment 00000 00000000
Solx 01-Sep-2006 Merger/Acquisition Diagnostic Equipment 00000 00000000
To view this company’s complete investment and acquisition history, request access »

TearLab Corporation Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 01-Sep-2006 000000000000000000 Completed
  • 0000000 0000000000
To view this company’s complete exits history, request access »

TearLab Corporation Subsidiaries (1)

Company Name Industry Location Founded
00000000 (000000 0 Other Healthcare MT
To view this company’s complete subsidiary history, request access »

TearLab Corporation Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore TearLab Corporation‘s full profile, request access.

Request full access to PitchBook

TearLab Corporation Executive Team (9)

Name Title Board
Seat
Contact
Info
Seph Jensen Chief Executive Officer
Michael Marquez Chief Financial Officer & Chief Accounting Officer
Michael Lemp Chief Medical Officer

6 Former Executives

You’re viewing 3 of 9 executives. Get the full list »

TearLab Corporation Board Members (8)

Name Representing Role Since Contact
Info
0000000 00000 TearLab Corporation Board Member 000 0000
00000 00000000 Self Chairman & Board Member 000 0000
0000 00000000 Self Board Member 000 0000
0000000 000000000 00 Self Board Member 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »